Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia

ClinicalTrials.gov ID: NCT01564784

Public ClinicalTrials.gov record NCT01564784. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AN OPEN-LABEL, RANDOMIZED PHASE 3 STUDY OF INOTUZUMAB OZOGAMICIN COMPARED TO A DEFINED INVESTIGATOR'S CHOICE IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY CD22-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the efficacy, in terms of complete responses and overall survival, of inotuzumab ozogamicin versus investigator's choice of chemotherapy.

Study identification

NCT ID
NCT01564784
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
326 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2, 2012 (Actual)
Primary completion
Mar 8, 2016 (Actual)
Completion
Jan 4, 2017 (Actual)
Last update posted
Jan 9, 2019

2012 – 2017

United States locations

U.S. sites
96
U.S. states
24
U.S. cities
42
Facility City State ZIP Site status
Investigational Drug Services - UC San Diego Moores Cancer Center La Jolla California 92037-0845 —
UC San Diego Medical Center - La Jolla La Jolla California 92037 —
UC San Diego Moores Cancer Center La Jolla California 92093-0698 —
Children's Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles Los Angeles California 90027 —
Keck Hospital of USC Los Angeles California 90033 —
LAC+USC Medical Center Los Angeles California 90033 —
USC Norris Comprehensive Cancer Center Los Angeles California 90033 —
USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles California 90033 —
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 —
UCLA Drug Information/Investigation Drug Los Angeles California 90095 —
UCLA Hematology/Oncology Clinic Los Angeles California 90095 —
UCLA Ronald Reagan Medical Center Los Angeles California 90095 —
UCLA Rrmc Los Angeles California 90095 —
UC Irvine Medical Center Orange California 92868-3201 —
Children's Hospital of Orange County Orange California 92868 —
UC Irvine Medical Center Orange California 92868 —
Freidenrich Center for Translational Research (CTRU), Stanford University Palo Alto California 94304 —
UC San Diego Medical Center - Hillcrest San Diego California 92103 —
Martha Hamilton, Investigational Drug Services, Dept of Pharmacy Stanford California 94305 —
Stanford Cancer Institute Stanford California 94305 —
Stanford University Hospital and Clinics Stanford California 94305 —
University of Colorado Cancer Center Aurora Colorado 80045 —
University of Colorado Hospital, Cancer Center Infusion Center Aurora Colorado 80045 —
University of Colorado Hospital Aurora Colorado 80045 —
Yale-New Haven Hospital & Smilow Cancer Center New Haven Connecticut 06510 —
Miami Children's Hospital Miami Florida 33155 —
MD Anderson Cancer Center Orlando - 5th Floor Investigational Pharmacy Orlando Florida 32806 —
MD Anderson Cancer Center Orlando Orlando Florida 32806 —
Orlando Heart Health Institute Orlando Florida 32806 —
Orlando Regional Medical Center Orlando Florida 32806 —
Emory University Hospital Atlanta Georgia 30322 —
Investigational Drug Service, Emory University Clinic Atlanta Georgia 30322 —
The Emory Clinic Atlanta Georgia 30322 —
Winship Cancer Institute, Emory University Atlanta Georgia 30322 —
Blood and Marrow Transplant Group of Georgia Atlanta Georgia 30342 —
Northside Hospital Atlanta Georgia 30342 —
Georgia Regents Medical Center Pharmacy, Georgia Regents University Cancer Center Augusta Georgia 30912 —
Georgia Regents University Augusta Georgia 30912 —
Northwestern Medical Faculty Foundation Chicago Illinois 60611 —
Northwestern Medicine Developmental Therapeutics Institute Chicago Illinois 60611 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
The University of Chicago Chicago Illinois 60637 —
University of Chicago Medical Center, Dept. of Pharmacy Chicago Illinois 60637 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
University of Kansas Hospital Kansas City Kansas 66160 —
University of Kansas Cancer Center Westwood Kansas 66205 —
Norton Cancer Institute Louisville Kentucky 40202 —
Norton Cancer Institute, Suburban Louisville Kentucky 40207 —
University of Maryland Baltimore Maryland 21201 —
Oncology Investigational Drug Service Baltimore Maryland 21231-2410 —
The Sidney Kimmel Comprehensive Cancer Center Baltimore Maryland 21231-2410 —
Massachusetts General Hospital (MGH) Boston Massachusetts 02114 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
University of Michigan Health System- Ann Arbor Michigan 48109 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Karmanos Cancer Institute Weisberg Cancer Treatment Center Farmington Hills Michigan 48334 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 —
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 —
University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico 87131-0001 —
UNM Cancer Center Albuquerque New Mexico 87131 —
Monter Cancer Center Lake Success New York 11042 —
North Shore University Hospital Manhasset New York 11030 —
New York Presbyterian Hospital-Weill Cornell Medical College New York New York 10021 —
NewYork-Presbyterian Hospital New York New York 10065 —
Weill Cornell Medical College - New York-Presbyterian Hospital New York New York 10065 —
University of Rochester Medical Center Rochester New York 14642 —
Stony Brook University Medical Center Stony Brook New York 11794-7007 —
Stony Brook University Medical Center, The Cancer Center Stony Brook New York 11794-9447 —
Division of Hematology/Oncology, Stony Brook University Hospital Stony Brook New York 11794 —
Stony Brook University Medical Center Stony Brook New York 11794 —
UNC Cancer Hospital Infusion Pharmacy Chapel Hill North Carolina 27514 —
UNC Hospitals - The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7600 —
Wake Forest Baptist Health Winston-Salem North Carolina 27157 —
University of Cincinnati Medical Center Cincinnati Ohio 45219 —
University Hospitals of Cleveland Cleveland Ohio 44106 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
OU Medical Center Presbyterian Tower Oklahoma City Oklahoma 73104 —
Stephenson Cancer Center Oklahoma City Oklahoma 73104 —
IDS-investigational drug pharmacy Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033 —
Penn State Milton S. Hershey Medical Center, Hershey Pennsylvania 17033 —
Hollings Cancer Center Charleston South Carolina 29425 —
MUSC Hospital Charleston South Carolina 29425 —
Parkland Health and Hospital System Dallas Texas 75235 —
Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Baylor University Medical Center Dallas Texas 75246 —
University of Texas Southwestern Universtiy Hospital - William P Clements Jr. Dallas Texas 75390 —
UT Southwestern Medical Center at Dallas Dallas Texas 75390 —
UT Southwestern University Hospital- Zale Lipshy Dallas Texas 75390 —
The University of Texas MD Anderson Cancer Center Houston Texas 77030 —
LDS Hospital Salt Lake City Utah 84143 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
University of Washington Seattle Washington 98195 —
West Virginia University Hospitals Pharmaceutical Services Morgantown West Virginia 26506 —
West Virginia University Hospitals Morgantown West Virginia 26506 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01564784, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 9, 2019 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01564784 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →